Pathogenesis and prospects for therapeutic clinical application of noncoding RNAs in glaucoma: Systematic perspectives

J Cell Physiol. 2021 Oct;236(10):7097-7116. doi: 10.1002/jcp.30347. Epub 2021 Feb 26.

Abstract

Noncoding ribonucleic acids (ncRNAs) are an increasingly studied class of RNA molecules with extensive biological activities, including important roles in human development, health, and disease. Glaucoma is a neurodegenerative disease of the retina, and one of the leading causes of blindness worldwide. However, the specific roles of ncRNAs in the development and progression of glaucoma are unclear, and related reports are fragmented. An in-depth understanding of ncRNAs participating in the pathogenesis and progression of glaucoma would be helpful for opening up new avenues to facilitate the early diagnosis and clinical treatment. Therefore, in this review, we aimed to discuss the current research progress, the potentialfuture clinical applications and the research limitations of three critical classes of ncRNAs in glaucoma, namely microRNAs, long noncoding RNAs, and circular RNAs.

Keywords: circular RNAs; glaucoma; long noncoding RNAs; microRNAs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Early Diagnosis
  • Gene Expression Regulation
  • Glaucoma / diagnosis
  • Glaucoma / genetics
  • Glaucoma / metabolism*
  • Glaucoma / therapy
  • Humans
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • MicroRNAs / therapeutic use
  • Predictive Value of Tests
  • Prognosis
  • RNA, Circular / genetics
  • RNA, Circular / metabolism*
  • RNA, Circular / therapeutic use
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism*
  • RNA, Long Noncoding / therapeutic use
  • Retina / metabolism*
  • Retina / pathology

Substances

  • Biomarkers
  • MicroRNAs
  • RNA, Circular
  • RNA, Long Noncoding